December 02, 2015
1 min read

High outcome scores found after coracoclavicular ligament reconstruction in non-revised patients

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact

Although investigators of this 2-year minimum follow-up study found 22.6% of patients who underwent primary anatomic coracoclavicular reconstruction using free tendon allografts required revision, they noted excellent function and patient satisfaction among patients who did not require revision. 

From October 2006 to January 2011, 31 patients with a mean age of 43.9 years underwent primary anatomic coracoclavicular ligament reconstruction using allografts for the treatment of Rockwood grade III or grade V acromioclavicular joint dislocations. Investigators collected patients’ SF-12, Single Assessment Numeric Evaluation (SANE), QuickDASH and the American Shoulder and Elbow Surgeons (ASES) scores, as well as patient satisfaction. Clinical assessments were conducted at 30-day intervals, at which time investigators obtained radiographs to assess joint reduction maintenance and heterotopic bone formation.

Investigators found eight patients developed complications and needed additional surgery for graft rupture/attenuation, clavicle fracture, distal clavicle hypertrophy or adhesive capsulitis.

Peter J. Millett

Of the patients who did not need additional surgery, investigators found postoperative ASES, SF-12 and median pain scales significantly improved compared with preoperative scores. At the last follow-up, investigators found these patients had mean SANE and ASES scores of 89.1 and 93.8, respectively. Patients rated their pain as a nine out of 10 and their QuickDASH score was 5.6. by Monica Jaramillo

Disclosures: Millett reports he receives support from Arthrex, GameReady and VuMedi. Please see the full study for a list of all other authors’ financial disclosures.